Single-Arm Study to Assess the Efficacy of UVADEX (Methoxsalen) Sterile Solution in Conjunction With the THERAKOS CELLEX Photopheresis System in Pediatric Patients With Steroid-Refractory Acute Graft Versus Host Disease (aGvHD)
Phase of Trial: Phase III
Latest Information Update: 30 Jun 2016
At a glance
- Drugs Methoxsalen (Primary)
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- Sponsors Mallinckrodt Inc.; Therakos
- 12 May 2016 Planned End Date changed from 1 May 2017 to 1 Nov 2018.
- 12 May 2016 Planned primary completion date changed from 1 Jan 2017 to 1 Oct 2018.
- 12 May 2016 Status changed from not yet recruiting to recruiting.